You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2014)

Docket	⤷ Sign Up	Date Filed	2014-12-18
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	7,297,703; 7,741,338
Link to Docket	External link to docket

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2014-12-18	1		United States Letters Patent No. 7,297,703 (“the ‘703 patent”). The ‘703 patent was duly and legally …United States Letters Patent No. 5,665,772 (“the ‘772 patent”). The ‘772 patent was duly and legally …United States Letters Patent No. 7,741,338 (“the ‘338 patent”). The ‘338 patent was duly and legally … the ‘772, ‘703 and ‘338 patents was an act of infringement of those patents. 23. …772 patent’s pediatric exclusivity, and June 6, 2020, the expiration of the ‘703 and ‘338 patents’ pediatric	External link to document
2016-02-11	102		Stipulation and Order of Dismissal regarding U.S. Patent Nos. 7,297,703 and 7,741,338. Signed by Judge Richard G…18 December 2014 1:14-cv-01494-RGA Patent None District Court, D. Delaware	External link to document
2014-12-18	4		Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 7,297,703; 7,741,338;. …18 December 2014 1:14-cv-01494-RGA Patent None District Court, D. Delaware	External link to document
2015-08-04	64		Claim Construction Brief Regarding U.S. Patent Nos. 7,297,703 and 7,741,338 filed by Roxane Laboratories…18 December 2014 1:14-cv-01494-RGA Patent None District Court, D. Delaware	External link to document
2015-09-14	67		Sur-Reply Claim Construction Brief Regarding US Patent Nos 7,297,703 and 7,741,338 filed by Par Pharmaceutical…18 December 2014 1:14-cv-01494-RGA Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.